GB0214147D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB0214147D0
GB0214147D0 GBGB0214147.1A GB0214147A GB0214147D0 GB 0214147 D0 GB0214147 D0 GB 0214147D0 GB 0214147 A GB0214147 A GB 0214147A GB 0214147 D0 GB0214147 D0 GB 0214147D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0214147.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0214147.1A priority Critical patent/GB0214147D0/en
Publication of GB0214147D0 publication Critical patent/GB0214147D0/en
Priority to TW092116417A priority patent/TW200404766A/zh
Priority to ARP030102145A priority patent/AR039691A1/es
Priority to US10/517,801 priority patent/US20050222260A1/en
Priority to AU2003278958A priority patent/AU2003278958A1/en
Priority to EP03740281A priority patent/EP1513511A1/en
Priority to JP2004514780A priority patent/JP2005533075A/ja
Priority to PCT/EP2003/006465 priority patent/WO2004000296A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GBGB0214147.1A 2002-06-19 2002-06-19 Formulations Ceased GB0214147D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0214147.1A GB0214147D0 (en) 2002-06-19 2002-06-19 Formulations
TW092116417A TW200404766A (en) 2002-06-19 2003-06-17 Pharmaceutical solid dosage forms
ARP030102145A AR039691A1 (es) 2002-06-19 2003-06-17 Formas de dosificacion solidas farmaceuticas
US10/517,801 US20050222260A1 (en) 2002-06-19 2003-06-19 (2S)-2-amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
AU2003278958A AU2003278958A1 (en) 2002-06-19 2003-06-19 (2s)-2amino-a-{(2-(ethanimidoylamino) ethyl)thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
EP03740281A EP1513511A1 (en) 2002-06-19 2003-06-19 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
JP2004514780A JP2005533075A (ja) 2002-06-19 2003-06-19 安定化された医薬製剤の一酸化窒素シンターゼ阻害剤（２ｓ）−２−アミノ−４−［２−（エタンイミドイルアミノ）エチル］チオブタン酸
PCT/EP2003/006465 WO2004000296A1 (en) 2002-06-19 2003-06-19 (2s)-2amino-a-{[2-(ethanimidoylamino) ethyl]thio}butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0214147.1A GB0214147D0 (en) 2002-06-19 2002-06-19 Formulations

Publications (1)

Publication Number Publication Date
GB0214147D0 true GB0214147D0 (en) 2002-07-31

Family

ID=9938915

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0214147.1A Ceased GB0214147D0 (en) 2002-06-19 2002-06-19 Formulations

Country Status (8)

Country Link
US (1) US20050222260A1 (enExample)
EP (1) EP1513511A1 (enExample)
JP (1) JP2005533075A (enExample)
AR (1) AR039691A1 (enExample)
AU (1) AU2003278958A1 (enExample)
GB (1) GB0214147D0 (enExample)
TW (1) TW200404766A (enExample)
WO (1) WO2004000296A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004017514D1 (de) * 2004-06-02 2008-12-11 Galephar M F Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2011052499A1 (ja) * 2009-10-28 2011-05-05 第一三共株式会社 貯蔵安定性が改善された医薬組成物
DE102011051304A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Wirkstoffmatrix
CN102908323B (zh) * 2012-10-30 2015-03-04 天津红日药业股份有限公司 一种含有莫西沙星的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957087B1 (en) * 1994-06-15 2002-12-04 The Wellcome Foundation Limited Intermediates useful in the preparation of enzyme inhibitors
WO1996001128A2 (de) * 1994-07-04 1996-01-18 Schering Aktiengesellschaft Niedrig dosierte steroidtabletten, die gallussäureester als antioxidans enthalten, verfahren zur herstellung und die verwendung
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
MY117948A (en) * 1997-01-13 2004-08-30 Glaxo Group Ltd Nitride oxide synthase inhibitors.
GB0031179D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
AR039691A1 (es) 2005-03-09
EP1513511A1 (en) 2005-03-16
WO2004000296A1 (en) 2003-12-31
TW200404766A (en) 2004-04-01
US20050222260A1 (en) 2005-10-06
JP2005533075A (ja) 2005-11-04
AU2003278958A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
IL162642A0 (en) Formulations
AU2003249738A8 (en) Ostoscope
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279911A8 (en) Therapeutic formulations
GB0323701D0 (en) Formulations
GB0207438D0 (en) Formulation
GB0205504D0 (en) Formulation
DE50303619D1 (en) Reibschweissvorrichtung
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
EP1503804A4 (en) RADIOPHARMACEUTICAL FORMULATIONS
DE50307787D1 (en) Isophthalsäurederivate
DE50311133D1 (en) Carbonsäureamide
DE50310169D1 (en) Lingual-retainer
GB0218194D0 (en) Solid formulations
GB0307765D0 (en) Tissue-adhesive formulations
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003262681A8 (en) Hemo-aide
DE10392833D2 (en) Geotextilie
GB0214147D0 (en) Formulations
GB0211145D0 (en) Herbal formulations
GB0310123D0 (en) Airfreshener combined luminair
AU2003253735A8 (en) Vacuolins
DE50309021D1 (en) Etherlacton
GB0218567D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)